Hat mitgewirkt an:
-
Pre-metastatic and immunological conditioning of the hepatic niche during melanoma progression
-
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
-
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
-
Lyve-1 deficiency enhances the hepatic immune microenvironment entailing altered susceptibility to melanoma liver metastasis